£1.7M of Innovate UK funding will help tackle silent killer that could affect one in four Scots
Eagle Genomics and the Stratified Medicine Scotland Innovation Centre (SMS-IC) have been awarded a £1.7M collaborative grant from Innovate UK (the UK’s innovation agency), for a ground-breaking project that could help develop new tests and treatments for patients with non-alcoholic fatty liver disease (NAFLD).
The project will involve genetic sequencing of 1000 liver biopsy samples from within NHS Scotland’s biorepository network by Edinburgh Genomics.